John Flavin
Oprichter bij PYXIS ONCOLOGY, INC.
Vermogen: 1 M $ op 31-05-2024
Profiel
John L.
Flavin is the founder of Pyxis Oncology, Inc. (founded in 2018) where he holds the title of Chairman.
He is also the founder of Portal Innovations LLC (founded in 2020) where he holds the title of CEO.
Mr. Flavin's current job(s) include being the Executive Chairman at ClostraBio, Inc. and the Manager at Flavin Ventures LLC.
Mr. Flavin's former job(s) include being the Chief Executive Officer at Emerald BioStructures, Inc., ThermoGen, Inc., and Advanced X-Ray Analytical Services, Inc. He was also the President, CFO, Secretary & Director at Advanced Life Sciences Holdings, Inc. from 2002 to 2011 and the Chief Operating Officer at MediChem Life Sciences, Inc. from 1991 to 2002.
Additionally, he served as the Chief Financial Officer at Endotronix, Inc. from 2018 to 2020.
Mr. Flavin's education history includes an undergraduate degree from Marquette University in 1991 and an MBA from Lewis University in 1995.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC.
0.64% | 18-04-2024 | 377 796 ( 0.64% ) | 1 M $ | 31-05-2024 |
Actieve functies van John Flavin
| Bedrijven | Functie | Begin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Oprichter | 11-06-2018 |
| Flavin Ventures LLC | Corporate Officer/Principal | 04-01-2010 |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Algemeen Directeur | 01-03-2022 |
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Voorzitter | - |
Eerdere bekende functies van John Flavin
| Bedrijven | Functie | Einde |
|---|---|---|
Endotronix, Inc.
 Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Financieel Directeur/CFO | 01-02-2020 |
| ADVANCED LIFE SCIENCES HOLDINGS, INC. | President | 05-05-2011 |
MediChem Life Sciences, Inc.
 MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | President | 01-05-2000 |
| Advanced X-Ray Analytical Services, Inc. | President | - |
ThermoGen, Inc.
 ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | President | - |
Opleiding van John Flavin
| Marquette University | Undergraduate Degree |
| Lewis University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 9 |
|---|---|
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
| Advanced X-Ray Analytical Services, Inc. | |
| Flavin Ventures LLC | |
Advanced Life Sciences Holdings, Inc.
 Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
